AU Patent
AU2007333394B2 — Compounds and compositions as protein kinase inhibitors
Assigned to Novartis AG · Expires 2011-02-03 · 15y expired
What this patent protects
Patent listed against Zykadia.
Drugs covered by this patent
- Zykadia (ceritinib) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.